Alcohol is linked with all-cause dementia in humans (association between probable sarcopenia and dementia risk) (12.8%).
“Mediation analysis elucidates that alcohol consumption explained 12.8%, 15.2%, and 11.1% of the associations of probable sarcopenia with the risk of ACD, AD, and VD, respectively.”
Humansassociation between probable sarcopenia and dementia risk
Multidimensional sleep health was not clearly linked with all-cause dementia in humans (Covariate-adjusted analyses in RS and MAP/MARS) (HRs between 0.72–1.15).
“Multidimensional sleep health scores and clusters were not significantly associated with accelerated cognitive decline or the risk of dementia in either sample”
HumansCovariate-adjusted analyses in RS and MAP/MARS10.6 ± 4.5 years in RS; 5.3 ± 2.9 years in MAP/MARS
Taurine was not clearly linked with all-cause dementia in humans (dietary intake adjusted for energy intake; prospective cohort).
“No significant associations were found between dietary taurine intake or plasma taurine concentrations and the risk of all-cause dementia, AD, or VaD.”
Humansdietary intake adjusted for energy intake; prospective cohortdietary intakemedian 25-year follow-upn = 27,786
Continuous positive airway pressure was not clearly linked with all-cause dementia in humans (HR 0.99, 95% CI 0.74–1.32).
“Individuals with OSAS who had received continuous positive airway pressure (CPAP) treatment exhibited a similar risk of all-cause dementia as their matched counterparts”
HumansIndividuals with obstructive sleep apnea syndrome receiving treatment compared with their matched counterparts
GDF-15 is linked with all-cause dementia in humans (Mediation of the relationship between physical activity and incident all-cause dementia) (21 unique proteins identified as mediators).
“GDF15, ITGAV, ITGAM, ITGA11, HPGDS, GFAP, ADM, AHNAK, and DPP4 were among 21 unique proteins found to mediate the relationship of PA with all-cause dementia”
HumansMediation of the relationship between physical activity and incident all-cause dementiaplasma
GDF-15 is linked with all-cause dementia in humans (mediating the association between degenerative joint diseases and all-cause dementia) (mediation proportion 22%, 95% CI 14.5–46.8%).
Chronic rhinosinusitis was not clearly linked with all-cause dementia in humans (Compared with individuals without chronic rhinosinusitis) (Adjusted HR 1.0, 95% CI 0.8–1.3).
“patients over 55 years of age with CRS did not exhibit an increased incidence or risk of dementia compared to individuals without CRS.”
HumansCompared with individuals without chronic rhinosinusitis
Inflammatory bowel disease was not clearly linked with all-cause dementia in humans (Compared with participants without inflammatory bowel disease) (HR 1.14, 95% CI 0.94–1.39; P=.182).
“Our study does not support a significant association between IBD and dementia.”
HumansCompared with participants without inflammatory bowel diseaseMean follow-up of 11.58 yearsn = 497,775
IGF-1 was not clearly linked with all-cause dementia in humans (Fully adjusted linear Cox model; per 1-SD increase in circulating IGF-1) (HR 1.01, 95% CI 1.00–1.01 per 1-SD increase).
“a 1‐SD increase in IGF‐1 was not linearly associated with all‐cause dementia (HR = 1.01, 95% CI: 1.00–1.01; p = 0.290).”
HumansFully adjusted linear Cox model; per 1-SD increase in circulating IGF-1n = 66,535
Loneliness was not clearly linked with all-cause dementia in humans (total or indirect effects).
“we found little evidence that hearing phenotypes or loneliness had clear total or indirect effects on Alzheimer's disease dementia or all-cause dementia”
medRxiv : the preprint server for health sciences·Preprint
HAVCR1
→mediatesin humans1
1 study
HAVCR1 is linked with all-cause dementia in humans (mediating the association between degenerative joint diseases and all-cause dementia) (mediation proportion 52.6%, 95% CI 39.1–78%).
“Mediation analysis revealed that 18 proteins, including HAVCR1 (mediation proportion 52.6 %, 95 % CI: 39.1 %-78 %)”
Humansmediating the association between degenerative joint diseases and all-cause dementia
Structural brain changes are linked with all-cause dementia in humans (Association between CKM stage and dementia incidence; mediation analysis) (Up to 15.7% of the CKM-dementia association explained).
“Mediation analyses indicated that structural brain changes, particularly WMH volume, explained up to 15.7 % of the CKM-dementia association.”
HumansAssociation between CKM stage and dementia incidence; mediation analysisbrain
Plasma taurine concentration was not clearly linked with all-cause dementia in humans (measured in a subset of participants).
“No significant associations were found between dietary taurine intake or plasma taurine concentrations and the risk of all-cause dementia, AD, or VaD.”
Humansmeasured in a subset of participantsmedian 25-year follow-upn = 3,693
Fine particulate matter is associated with all-cause dementia in humans (HR 1.48, 95% CI 1.15–1.90).
“Greater than average annual exposure was associated with an increased risk of all-cause dementia (PM 2.5 , (Hazard Ratio [95% Confidence Interval] (HR [95%CI]) = 1.48 [1.15–1.90]”
HumansGreater than average annual exposure18 years of follow-up
SGLT2 inhibitors are linked with a lower risk of all-cause dementia in humans (intention-to-treat analysis in patients with mood or psychotic disorders) (OR 0.61 (95% CI 0.52-0.73)).
“SGLT2 inhibitor use was associated with reduced odds of all-cause dementia (odds ratio [OR], 0.61; 95% CI, 0.52-0.73)”
Humansintention-to-treat analysis in patients with mood or psychotic disorders
SGLT2 inhibitors are linked with a lower risk of all-cause dementia in humans (compared with DPP-4 inhibitors in type 2 diabetes) (33% lower risk; IRR 0.666 (95% CI 0.484-0.918)).
“SGLT2 inhibitor use was associated with a 33 % lower risk of all-cause dementia compared to DPP-4 inhibitors”
Humanscompared with DPP-4 inhibitors in type 2 diabetes
SGLT2 inhibitors are associated with all-cause dementia in humans (Type 2 diabetes mellitus; compared with GLP-1 receptor agonist users) (OR 0.85, 95% CI 0.77-0.94).
“Compared with GLP-1RA users, SGLT-2i users had lower rates of all-cause dementia (OR 0.85, 95% CI 0.77-0.94; P = 0.001)”
ReviewType 2 diabetes mellitus; compared with GLP-1 receptor agonist users
GFAP is linked with a higher risk of all-cause dementia in chronic pain individuals; plasma proteomics (HR 2.26 for all-cause dementia (AD HR 2.62; VD HR 2.93)).
“GFAP showed the strongest association with all dementia types (ACD: HR=2.26; AD: HR=2.62; VD: HR=2.93).”
GFAP is associated with all-cause dementia in humans (Without prevalent dementia at baseline) (HR 2.47, 95% CI 1.52–4.01).
“each standard deviation unit increase in log-transformed GFAP levels was significantly associated with a 2.5-fold higher risk of incident all-cause dementia”
ReviewWithout prevalent dementia at baselinePer standard deviation increase in log-transformed GFAPUp to 15 yearsn = 4,338
Physical activity is linked with a lower risk of all-cause dementia in premenopausal females (aHR=0.830, 95% CI 0.739-0.931).
“Regular physical activity was associated with a reduced risk of all-cause dementia and AD, but not VaD in premenopausal females (aHR=0.830, 95% confidence interval [CI]=0.739-0.931)”
Physical activity is associated with all-cause dementia in humans (Dementia-free at baseline; midlife physical activity) (Q5 versus Q1: HR 0.59, 95% CI 0.40–0.88; Q4 versus Q1: HR 0.60, 95% CI 0.41–0.89).
“Midlife and late-life physical activity levels in Q4 or Q5 were associated with lower risk of all-cause dementia compared with Q1”
HumansDementia-free at baseline; midlife physical activityQ5 versus Q1Mean 25.9 yearsBothsn = 1,943
Hormone replacement therapy is linked with a lower risk of all-cause dementia in postmenopausal women with chronic kidney disease; adjusted Cox regression (HR 0.80; 95% CI 0.78-0.82).
“HRT was significantly associated with a lower risk for dementia in the adjusted Cox regression model”
Humansin postmenopausal women with chronic kidney disease; adjusted Cox regressionfemalesn = 755,426
Hormone replacement therapy is associated with all-cause dementia in humans (women with a uterus; compared with placebo or no menopausal hormone therapy) (HR 1.12, 95% CI 0.91–1.31).
“There was no significant increased risk in women with a uterus for all cause dementia (pooled hazard ratio (HR): 1.12; 95% CI 0.91-1.31, N=78,613,”
Reviewwomen with a uterus; compared with placebo or no menopausal hormone therapysystemicfemalesn = 78,613
Depression is linked with a higher risk of all-cause dementia in humans (cancer survivors, depression diagnosed >5 years after cancer (time-varying model)) (aHR 2.09, 95% CI 2.02-2.17).
“time-varying models showed consistently elevated risks across all depression-onset intervals, including >5 years after cancer (aHR, 2.09; 95% CI, 2.02-2.17).”
Humanscancer survivors, depression diagnosed >5 years after cancer (time-varying model)11.7 years median follow-upn = 385,092
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·
Depression is linked with a higher risk of all-cause dementia in humans (HR 1.59, 95% CI 1.50 to 1.69).
“Depression conferred a 1.59-fold excess risk for dementia (pooled HR: 1.59, 95% CI 1.50 to 1.69; I2=56.8%).”
Smoking is associated with all-cause dementia in humans (New smokers compared with never smokers after ischemic stroke) (aHR 1.395, 95% CI 1.254-1.552).
“new smokers, sustained smokers, and smoking quitters were significantly associated with a higher risk of all-cause dementia than never smokers”
HumansNew smokers compared with never smokers after ischemic strokeMedian follow-up of 4.04 yearsn = 197,853
Diabetes mellitus is linked with a higher risk of all-cause dementia in humans (compared with participants without diabetes and thyroid disorders) (HR 1.76, 95% CI 1.64–1.89).
“only diabetes (HR = 1.76, 95% CI = 1.64 to 1.89, P < 0.001)”
Humanscompared with participants without diabetes and thyroid disorders
Periodontal disease is linked with a higher risk of all-cause dementia in humans (weighted median model, alternative approach II (p < 10−4)) (beta: 0.077, 95% CI (0.006, 0.149)).
“and the weighted median model from alternative approach II (beta: 0.077 95%CI (0.006, 0.149)) suggested potential causal relationship between periodontal diseases and dementia.”
Humansweighted median model, alternative approach II (p < 10−4)
Periodontal disease is linked with a lower risk of all-cause dementia in humans (IVW model, main approach (p < 5 × 10−8)) (beta: -0.816, 95% CI (-1.617, -0.015)).
“Most MR results suggested no causal association between periodontal diseases and dementia except the IVW model from main approach (coefficient beta: -0.816, 95% confidence interval, CI (-1.617, -0.015))”
Above-average exposure was linked to dementia and heart attack, with hazard ratios of 1.48 and 1.79, respectively, compared with lower exposure.Above-average exposure was linked to dementia and heart attack, with hazard ratios of 1.48 and 1.79, respectively, compared with lower exposure.
Dementia or mild cognitive impairment occurred at 3.69 versus 3.89 events per 100 person-years with intensive versus standard treatment over a median 3.8 years.Dementia or mild cognitive impairment occurred at 3.69 versus 3.89 events per 100 person-years with intensive versus standard treatment over a median 3.8 years.
Who was studied12,434 adults with type 2 diabetes, against standard blood pressure treatment
What changedDementia or mild cognitive impairment showed no clear difference with intensive versus standard blood pressure treatment (hazard ratio 0.96)
The catchMissed mild cognitive impairment at baseline could dilute the apparent treatment effect